Christobel Selecky sold $438K of ImmunityBio (IBRX)

Executed Jan 16, disclosed Jan 21, 5 days later.

Value, as filed

$438K

75,000 sh across 2 lots

Executed

Jan 16

the trade date, as filed

Disclosed

Jan 21

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CS Christobel Selecky Director profile →

Christobel Selecky (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in ImmunityBio, Inc. (IBRX). The largest single filing was $1.4M of IBRX (159,478 sh × $9.02, as filed), executed Jul 1.

The name

IBRX ImmunityBio, Inc. IBRX · Healthcare · 10 filings in 24 months ticker →

Healthcare · ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christobel Selecky in IBRX

IBRXSALE ImmunityBio, Inc. $1.4M
159,478 sh × $9.02
Exec Jul 1
Filed Jul 6 · 8:25 PM ET IBRXSALE ImmunityBio, Inc. $862K
95,722 sh × $9.01
Exec Jun 29
Filed Jul 1 · 5:04 PM ET IBRXSALE ImmunityBio, Inc. $250K
25,000 sh × $10.00
Exec Feb 23
Filed Feb 24 · 5:30 PM ET